UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000033645 |
|---|---|
| Receipt number | R000038363 |
| Scientific Title | A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of AG-348 in Not Regularly Transfused Adult Subjects with Pyruvate Kinase Deficiency |
| Date of disclosure of the study information | 2018/08/06 |
| Last modified on | 2021/11/10 15:30:50 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2018/08/06 20:31:43 | ||
| 2 | Update | 2021/11/05 14:15:39 | UMIN ID1 |
|
| 3 | Update | 2021/11/09 13:42:14 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Organization Organization Zip code Address Address TEL Name of person sending information Name of person sending information Organization Organization Division name Division name Address Address TEL Institute Institute Organization Organization Address Address Tel |
|
| 4 | Update | 2021/11/09 14:05:33 | Recruitment status Date of IRB Last follow-up date |
|
| 5 | Update | 2021/11/09 14:06:08 | Publication of results URL related to results and publications Number of participants that the trial has enrolled |
|
| 6 | Update | 2021/11/09 14:33:48 | Last name of contact person Last name of contact person TEL |
|
| 7 | Update | 2021/11/10 15:30:50 | Last name of contact person Last name of contact person Division name Division name TEL |
